Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria

This publication has 19 references indexed in Scilit:

• In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin
  Antimicrobial Agents and Chemotherapy, 1984
• Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro Characteristics
  Clinical Infectious Diseases, 1983
• The New Beta-Lactamase-Stable Cephalosporins
  Annals of Internal Medicine, 1982
• Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, -lactamase stability, and inhibition
  Journal of Antimicrobial Chemotherapy, 1982
• Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria
  Antimicrobial Agents and Chemotherapy, 1981
• Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test
  Antimicrobial Agents and Chemotherapy, 1981
• Cefoperazone
  Drugs, 1981
• Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests
  Journal of Antimicrobial Chemotherapy, 1981
• In vitro evaluation of LY127935 (6059S) compared with cefotaxime, eight other β-lactams and two aminoglycosides
  Journal of Antimicrobial Chemotherapy, 1980
• In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains
  Antimicrobial Agents and Chemotherapy, 1980